During the past decade, The Royal Marsden Nhs Foundation Trust - Chelsea conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Royal Marsden Nhs Foundation Trust - Chelsea" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Royal Marsden Nhs Foundation Trust - Chelsea" are "Adult-type Diffuse Gliomas" (1 trials), "Borderline Ovarian Serous Tumor" (1 trials), "Follicular Lymphoma" (1 trials), "Glioblastoma" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "The Royal Marsden Nhs Foundation Trust - Chelsea" in a lesser frequency.

Most popular intervention types in "The Royal Marsden Nhs Foundation Trust - Chelsea" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Gemcitabine" (2 trials), "Pemigatinib" (2 trials), "retifanlimab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Royal Marsden Nhs Foundation Trust - Chelsea" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Royal Marsden Nhs Foundation Trust - Chelsea". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Royal Marsden Nhs Foundation Trust - Chelsea, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Royal Marsden Nhs Foundation Trust - Chelsea, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".